T Cell News and Research

Latest T Cell News and Research

Common catalyst cerium oxide opens door to nanochemistry for medicine

Scientists at Rice University are enhancing the natural antioxidant properties of an element found in a car's catalytic converter to make it useful for medical applications.

16 Oct 2013

Research shows inhibition of Rcan1 protein may reduce atherosclerosis in mice

Researchers of the Spanish research council (Consejo Superior de Investigaciones Cient-ficas, CSIC) and the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have discovered that inhibiting the protein Rcan1 in mice reduces the burden of atherosclerosis, one of the commonest cardiovascular diseases.

16 Oct 2013

Researchers test ATR-101 compound in clinical trial for adrenal cancer

One of the most challenging cancers to treat is also one of the rarest, which only adds to the challenge of finding potential new therapies.

16 Oct 2013

Researchers develop potential new tool for speedier detection of food pathogens

Researchers have developed a system that concentrates foodborne salmonella and other pathogens faster than conventional methods by using hollow thread-like fibers that filter out the cells, representing a potential new tool for speedier detection.

16 Oct 2013

Ghrelin hormone released during chronic stress may predispose people to PTSD

About a dozen years ago, scientists discovered that a hormone called ghrelin enhances appetite. Dubbed the "hunger hormone," ghrelin was quickly targeted by drug companies seeking treatments for obesity - none of which have yet panned out.

16 Oct 2013

Researchers develop new method to produce artificial membranes using nanoscaled tip

Researchers around Dr. Michael Hirtz from Karlsruhe Institute of Technology and Dr. Aravind Vijayaraghavan from the University of Manchester have developed a new method to produce artificial membranes: Using a nanoscaled tip, they write tailored patches of phospholipid membrane onto a graphene substrate.

16 Oct 2013

New method may pave way to effective, targeted cancer treatments

Researchers from the University of Minnesota, Mayo Clinic, and University of Toronto have successfully shown that a new method for targeting mutated cells could create a major breakthrough in a personalized medicine approach to treat cancer.

16 Oct 2013

IRCM researchers identify new proteins crucial for hearing

A team of researchers led by Dr. Michel Cayouette at the IRCM made an important discovery, published online yesterday by the scientific journal Developmental Cell, that could better explain some inherited forms of hearing loss in humans. The Montr-al scientists identified a group of proteins crucial for shaping the cellular organ responsible for detecting sounds.

16 Oct 2013

Researchers develop innovative 3D method to grow miniature pancreas from progenitor cells

An international team of researchers from the University of Copenhagen have successfully developed an innovative 3D method to grow miniature pancreas from progenitor cells. The future goal is to use this model to help in the fight against diabetes. The research results has just been published in the scientific journal Development.

16 Oct 2013

UCSD professor receives $6.25M grant to support research on chronic lymphocytic leukemia

The Leukemia & Lymphoma Society has awarded Thomas J. Kipps, MD, PhD, Distinguished Professor of Medicine at the University of California, San Diego School of Medicine, with a 5-year, $6.25 million Specialized Center of Research program grant to support research on chronic lymphocytic leukemia (CLL), the most common adult leukemia in the United States.

16 Oct 2013

microRNAs may serve as therapeutic targets and predictors of metastasis

A class of molecules called microRNAs may offer cancer patients two ways to combat their disease.

15 Oct 2013

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

House dust mite allergy is a surprisingly prevalent problem. Something like 27% of the U.S. population and 20% of the European population are what’s called skin-prick test positive for house dust mites, which is a test for sensitivity to allergens to find out if a person is likely to get that allergy.

15 Oct 2013

immatics biotechnologies closes €34 million Series D financing round

immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced multi-peptide cancer vaccines that are active against cancer, today announced that it has closed a €34 million Series D financing round.

15 Oct 2013

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

Crown Bioscience, Inc., a leading global drug discovery and development service company, today announces that it has entered into a collaboration with Xstrahl Ltd, a leading designer and manufacturer of X-Ray solutions for radiation biology research.

From Xstrahl 15 Oct 2013

Promising new type of cancer treatment to benefit more patients

More patients than ever stand to benefit from a promising new type of cancer treatment, after scientists compiled a library of molecules that can prime patients’ immune systems to fight a range of cancers including leukaemia, myeloma, lung cancer and skin cancer.

15 Oct 2013

Barcelona to host European Drosophila Research Conference

From 16 to 19 October, more than 700 international scientists will attend the European Drosophila Research Conference, the most important European conference focused on basic and biomedical research that uses the fly fruit, Drosophila melanogaster, as a model system.

15 Oct 2013

NICE issues second draft guidance on PIXUVRI for treatment of aggressive B-cell NHL

Cell Therapeutics, Inc. today announced that the National Institute for Health and Care Excellence, a non-departmental public body of the Department of Health in the United Kingdom, issued second draft guidance on PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.

15 Oct 2013

Modeling, identifying predictors of Parkinson's disease with stem cells

The New York Stem Cell Foundation Research Institute has entered into a partnership with the Parkinson's Progression Markers Initiative to build resources for studying Parkinson's disease to accelerate new treatments. Sponsored by The Michael J. Fox Foundation for Parkinson's Research, PPMI is a landmark effort to identify and validate biomarkers of Parkinson's disease.

15 Oct 2013

New optical imaging technique can accurately differentiate breast cancer subtypes

An optical imaging technique that measures metabolic activity in cancer cells can accurately differentiate breast cancer subtypes, and it can detect responses to treatment as early as two days after therapy administration, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

15 Oct 2013

Mayo Clinic: Physical activity is associated with reduced risk of esophageal cancer

Physical activity is associated with a reduced risk of esophageal cancer, according to a new study presented by Mayo Clinic researchers at the American College of Gastroenterology's Annual Scientific Meeting, Oct. 11-16, in San Diego.

15 Oct 2013

T Cell News and Research

Latest T Cell News and Research

Common catalyst cerium oxide opens door to nanochemistry for medicine

Research shows inhibition of Rcan1 protein may reduce atherosclerosis in mice

Researchers test ATR-101 compound in clinical trial for adrenal cancer

Researchers develop potential new tool for speedier detection of food pathogens

Ghrelin hormone released during chronic stress may predispose people to PTSD

Researchers develop new method to produce artificial membranes using nanoscaled tip

New method may pave way to effective, targeted cancer treatments

IRCM researchers identify new proteins crucial for hearing

Researchers develop innovative 3D method to grow miniature pancreas from progenitor cells

UCSD professor receives $6.25M grant to support research on chronic lymphocytic leukemia

microRNAs may serve as therapeutic targets and predictors of metastasis

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

immatics biotechnologies closes €34 million Series D financing round

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

Promising new type of cancer treatment to benefit more patients

Barcelona to host European Drosophila Research Conference

NICE issues second draft guidance on PIXUVRI for treatment of aggressive B-cell NHL

Modeling, identifying predictors of Parkinson's disease with stem cells

New optical imaging technique can accurately differentiate breast cancer subtypes

Mayo Clinic: Physical activity is associated with reduced risk of esophageal cancer

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in